News

Tower Cold Chain acquired by Cold Chain Technologies

Pharma
Cold Chain Technologies has acquired Tower Cold Chain, combining their expertise in advanced thermal packaging, digital solutions and passive cold chain products.

Tower Cold Chain, which was founded in 1999, designs, manufactures and operates advanced passive reusable temperature-controlled containers for transporting high-value life science products.

From its UK headquarters and network of more than 20 service hubs, Tower Cold Chain supports pharmaceutical and life science customers.

It is Cold Chain Technologies’ fourth acquisition since partnering with Aurora Capital Partners in 2019.

During this time, it has expanded its product portfolio of sustainable packaging solutions, entered new life science verticals, launched its digital platform and grown its manufacturing and service capabilities.

Ranjeet Banerjee, CEO of Cold Chain Technologies, says, “We are thrilled to partner with Niall and the entire Tower team to offer exciting new products and geographic service capabilities to our current and prospective customers. This combination further establishes CCT as the leader in temperature-controlled packaging solutions with unmatched thermal engineering expertise, digital monitoring and tracking, global manufacturing, and commitment to sustainability.”

Niall Balfour, CEO of Tower Cold Chain, adds, “We have long admired CCT as a leader in our industry and believe it is the ideal partner to support Tower’s next chapter of growth. We look forward to working with Ranjeet and his team to better serve our customers, our employees, and the entire life sciences community.”